Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Lupus
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Lupus
    TopAbstracts in Lupus 11/23/2009 - (DGNews)
    TopAbstracts in Lupus 11/09/2009 - (DGNews)
    Recurrent Lupus Nephritis in Kidney Transplant Recipients With SLE Can Be Predicted: Presented at Renal Week 2009 - (DGDispatch)
    TopAbstracts in Lupus 10/26/2009 - (DGNews)
    Belimumab Reduces Systemic Lupus Erythematosus Disease Activity, Flares, and Prednisone Usage: Presented at ACR/ARHP - (DGDispatch)

    News archive

     Recent webcasts/CME - Lupus
      The Epidemiology of Increased Cardiovascular Death in Inflammatory Arthritis
      Systemic Lupus Erythematosus: Pathology, Diagnosis, and Treatment
      The Faces of SLE: Assessing Disease Activity, Response to Therapy, and Control of Comorbidities
      Advances in B-Cell Biology in the Treatment of Autoimmune and Inflammatory Diseases
      Neuroinflammatory Diseases in Rheumatology

      Webcasts/CME archive

       Recent cases - Lupus
        HELLP Syndrome, Multiple Liver Infarctions, and Intrauterine Fetal Death in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
        Infestation by Norwegian scabies
        Giant Coronary Aneurysm in a Patient with Systemic Lupus Erythematosus
        Multisystem Failure Due to Three Coexisting Autoimmune Diseases
        Primary Osteosarcoma of the Urinary Bladder Following Cyclophosphamide Therapy for Systemic Lupus Erythematosus: A Case Report

        Cases archive
          




        my personal edition > lupus > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Omega-3 Fish Oil Improves Lupus Symptoms, Shows Possible Cardiovascular Benefits: Presented at ACR

        By Bruce Sylvester

        BOSTON, MA -- November 12, 2007 -- Dietary supplementation with low-dose omega-3 fish oils improves lupus symptoms and shows evidence of a protective cardiovascular effect, according to researchers.

        The findings of a randomized, double-blind, placebo-controlled parallel trial of the effect of omega-3-polyunsaturated fatty acids on patients with systemic lupus erythematosus (SLE) were highlighted in a press briefing at the 71st annual meeting of the American College of Rheumatology (ACR) on November 9.

        "This is the first study in lupus patients measuring improvements in blood vessel function," said presenter and investigator Stephen Wright, MD, Specialist Registrar in Rheumatology, Department of Therapeutics and Musculoskeletal Education and Research Unit, Queen's University Hospital, Belfast, United Kingdom.

        "After 6 months we saw evidence confirming the beneficial effects of omega-3 fish oils for improving symptoms of lupus and, also, evidence of a cardioprotective effect in these patients," he added.

        Sixty patients participated in the trial. They received 3 g of omega-3 fish oils daily, for 24 weeks. The investigators measured disease activity using the revised Systemic Lupus Activity Measure (SLAM-R) and the British Isles Lupus Assessment Group (BILAG) index of disease activity for SLE. Endothelial function was measured by flow mediated dilation (FMD) of the brachial artery, oxidative stress using platelet 8-isoprostanes, and analysis of platelet membrane fatty acids. Readings were conducted at baseline, 12, and 24 weeks.

        The researchers reported that, in the fish oil group, there were statistically significant improvements at 24 weeks in lupus disease activity with changes in SLAM-R (P <.001), in BILAG (P <.001), and in FMD (P <.001).

        The investigators also reported improvements in platelet 8-isoprostanes (P =.007).

        The authors concluded, "Low-dose dietary supplementation with omega-3 fish oils in SLE not only has a therapeutic effect on disease activity but also improves endothelial function and reduces oxidative stress and may, therefore, confer cardiovascular benefits."


        [Presentation title: A Randomised Placebo-Controlled Interventional Trial of Omega-3-Polyunsaturated Fatty Acids on Disease Activity and Endothelial Function in Systemic Lupus Erythematosus. Abstract: 1317]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send